Subcutaneous immunoglobulin therapy for the treatment of multifocal motor neuropathy: a case report
- 24 June 2010
- journal article
- case report
- Published by Springer Nature in Neurological Sciences
- Vol. 31 (6) , 829-831
Abstract
Multifocal motor neuropathy (MMN) is a rare immune-mediated disease characterized by slowly progressive, asymmetric, predominantly distal weakness of one or more limbs without sensory loss. The first line of treatment is high-dose intravenous immunoglobulins (IVIg). Subcutaneous immunoglobulins (SCIg)already approved for the treatment of primary immune deficiency have recently been proposed also for the treatment of disimmune peripheral neuropathies such as MMN, and a few trials were performed to see if patients receiving immunomodulatory doses of IVIg could be treated equally well with SCIg. We describe a patient affected by MMN who was included in a protocol of treatment with SCIg for a period of 6 months. He successfully responded to treatment with a stabilization of strength. The patient is still treated with SCIg even after the end of the protocol. This is the first description of an Italian case of a patient affected by MMN successfully treated with SCIg.Keywords
This publication has 12 references indexed in Scilit:
- Subcutaneous immunoglobulin therapy for multifocal motor neuropathyJournal of the Peripheral Nervous System, 2009
- Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single‐blinded cross‐over trialEuropean Journal of Neurology, 2009
- Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy2009
- Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trialThe Lancet Neurology, 2008
- Intravenous immunoglobulin for multifocal motor neuropathyCochrane Database of Systematic Reviews, 2005
- Multifocal motor neuropathy: Current concepts and controversiesMuscle & Nerve, 2005
- Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at homeJournal of Allergy and Clinical Immunology, 2004
- Subcutaneous immunoglobulins: Alternative for the hypogammaglobulinemic patient?Journal of Allergy and Clinical Immunology, 2004
- Demyelination and axonal loss in multifocal motor neuropathy: distribution and relation to weaknessBrain, 2003
- Consensus criteria for the diagnosis of multifocal motor neuropathyMuscle & Nerve, 2002